Navigation Links
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
Date:6/15/2009

The Company's unaudited interim Consolidated Statements of Operations and Cash Flows for the three and nine month periods ended April 30, 2009 and 2008 are summarized below:

    Consolidated Statements of Operations
    for the three and nine month periods ended April 30, 2009 and 2008
    ($ thousands, except for per share data)

                                          Three months         Nine months
                                         ended April 30       ended April 30
                                         2009      2008       2009      2008
    Revenue:
     Product revenue                      793       775      2,454     2,181
     License fees and royalties           131       243        452       513
                                          924     1,018      2,906     2,694
    Expenses:
     Cost of sales                        375       326      1,160       908
     Research and development           3,082     1,068      7,584     2,879
     Operating, general and admin       1,231     1,060      3,854     3,618
     Amortization of intangible assets      3         3          9        13
     Amortization of capital assets        64        61        191       190
     Stock-based compensation             234        12        865        36
     Interest income, net                 (27)     (180)      (332)     (465)
     Foreign exchange loss / (gain)        67      (220)       199      (265)
                                        5,029     2,130     13,530     6,914


    Loss before income taxes           (4,105)   (1,112)   (10,624)   (4,220)

    Income taxes                           29        27         83        89

    Loss for the period                (4,134)   (1,139)   (10,707)   (4,309)

        Loss per share:
         Basic                          (0.08)    (0.03)     (0.21)    (0.11)
         Diluted                        (0.08)    (0.03)     (0.21) 
'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Sales Horizons, a ... its online sales training course – Mastering the ... sales performance. , Drawn from proven sales training programs ... Mastering the Complex Sale online sales training course is ... who has face-to-face contact with customers, like technical support, ...
(Date:7/30/2014)... 30, 2014 W. R. Grace ... of the REVELERIS® Prep purification system , ... chromatographers, and other researchers to perform both flash ... unit. , With the REVELERIS® Prep purification system, ... chromatography modes with a simple touch of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears ... American Academy of Dermatology (Academy) in an effort to ... Chicago Bears will host free SPOT me™ skin cancer ... 2 at Soldier Field. SPOT me™ is an ... about the dangers and risks of skin cancer, and ...
(Date:7/30/2014)... Selexis SA , a serial innovation company ... cell line development, announced today new data from the ... at the 10th Annual Cell Line Development and ... 2014 at the Double Tree by Hilton Berkeley Marina ... be presented during an oral presentation: , Title: Genome ...
Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Grace Launches New REVELERIS® Prep Purification System 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... Government ... Order and ... of,advanced technology solutions for homeland and military security, announced,today a ... of airborne biological threats. The AirSentinel,sensors, developed with support from ...
... EPI-Q, Inc., a consulting firm,providing outcomes research ... healthcare industries, announces the addition of,Anthony J. Vita, ... team of clinical,professionals. The specialized background of these ... to offer directly to those clients,seeking to enhance ...
... -,- 3Q07 Net Income Increased 58% Compared to 3Q06 to $11.9 Million, or ... ... Provides Financial Outlook for 2007 and 2008 -, NEW YORK, Nov. 5 ... of,plant-based pharmaceutical and nutraceutical products, today announced,financial results for the third quarter of ...
Cached Biology Technology:ICx Awarded Department of Defense Contract for AirSentinel Monitors 2EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD 2American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 2American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 3American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 4American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 5American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 6American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 7American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 8
(Date:7/30/2014)... Monash University Professor Steven Chown has been awarded ... Medal for Excellence in Antarctic Research. , SCAR, ... coordinates high quality international scientific research in the ... Antarctic region in the Earth system. The organisation ... Antarctic Treaty System, responsible for governing the region. ...
(Date:7/30/2014)... iodine-125 (125I) in cancer treatment has been shown ... are critical for neural transmission between the peripheral ... colleagues from Institute of Radiation Medicine, Chinese Academy ... be implanted into rat dorsal root ganglia (DRG) ... with different radioactivity (0, 14.8, 29.6 MBq) were ...
(Date:7/30/2014)... stem cells can develop into a multitude of cells types. ... into the specific types of mature cells that make up ... One key seems to be long chains of sugars that ... group at the University of California, San Diego, has created ... but can be more easily manipulated to direct the process, ...
Breaking Biology News(10 mins):
... Australian medical research has given pregnant women with epilepsy new ... physical birth defects. According to research published in the ... of the American Academy of Neurology, epilepsy experts at ... doses of common epilepsy drug valproate and the increased risk ...
... Medicine and Dentistry has received an award of 94,365 ... Reduction of Animals in Research (NC3Rs), for a pilot study ... cell which could be used in place of the live ... Macrophages are crucial components of the immune system and ...
... 22, 2013   Valid USA continues the expansion ... that it has acquired ScreenCheck North America (SCNA) ... the worldwide exclusive licensee for Polaroid ® identification ... to provide AAMVA compliant Real ID solutions. SCNA also ...
Cached Biology News:Epilepsy drug dosage linked to specific birth defects 2Funding for animal testing alternative 2Valid USA Continues Growth with Acquisition of ScreenCheck North America 2